SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-018826
Filing Date
2024-02-22
Accepted
2024-02-22 16:34:37
Documents
5
Effectiveness Date
2024-02-22

Document Format Files

Seq Description Document Type Size
1 S-8 rlay_-_s-8_2024.htm S-8 122618
2 EX-5.1 rlay-ex5_1.htm EX-5.1 15970
3 EX-23.1 rlay-ex23_1.htm EX-23.1 3640
4 EX-FILING FEES rlay-exfiling_fees.htm EX-FILING FEES 43475
5 GRAPHIC img142084332_0.jpg GRAPHIC 11480
  Complete submission text file 0000950170-24-018826.txt   202739
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277278 | Film No.: 24665421
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)